These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15879686)

  • 1. Treatment in animal models.
    Guan J; Bennet L; Gluckman PD; Gunn AJ
    Endocr Dev; 2005; 9():31-43. PubMed ID: 15879686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-1 and post-ischemic brain injury.
    Guan J; Bennet L; Gluckman PD; Gunn AJ
    Prog Neurobiol; 2003 Aug; 70(6):443-62. PubMed ID: 14568359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.
    Sizonenko SV; Sirimanne ES; Williams CE; Gluckman PD
    Brain Res; 2001 Dec; 922(1):42-50. PubMed ID: 11730700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for ischemic brain injury.
    Guan J
    Recent Pat CNS Drug Discov; 2008 Jun; 3(2):112-27. PubMed ID: 18537771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.
    Guan J; Thomas GB; Lin H; Mathai S; Bachelor DC; George S; Gluckman PD
    Neuropharmacology; 2004 Nov; 47(6):892-903. PubMed ID: 15527823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for treating neurological conditions.
    Guan J; Mathai S; Liang HP; Gunn AJ
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):142-60. PubMed ID: 23597305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
    Guan J; Gluckman PD
    Br J Pharmacol; 2009 Jul; 157(6):881-91. PubMed ID: 19438508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricular application of insulin-like growth factor 1 and its N-terminal tripeptide on cerebral recovery following cardiac arrest in rats.
    Knapp J; Teschendorf P; Vogel P; Bruckner T; Böttiger BW; Popp E
    Resuscitation; 2013 May; 84(5):684-9. PubMed ID: 23103885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders.
    Guan J; Harris P; Brimble M; Lei Y; Lu J; Yang Y; Gunn AJ
    Expert Opin Ther Targets; 2015 Jun; 19(6):785-93. PubMed ID: 25652713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I).
    Smith PF
    IDrugs; 2003 Dec; 6(12):1173-7. PubMed ID: 14666428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
    Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
    Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperature during recovery.
    Guan J; Gunn AJ; Sirimanne ES; Tuffin J; Gunning MI; Clark R; Gluckman PD
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):513-9. PubMed ID: 10724116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.
    Guan J; Waldvogel HJ; Faull RL; Gluckman PD; Williams CE
    Neuroscience; 1999 Mar; 89(3):649-59. PubMed ID: 10199602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat.
    Baker AM; Batchelor DC; Thomas GB; Wen JY; Rafiee M; Lin H; Guan J
    Neuropeptides; 2005 Apr; 39(2):81-7. PubMed ID: 15752541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed IGF-1 treatment reduced long-term hypoxia-ischemia-induced brain damage and improved behavior recovery of immature rats.
    Zhong J; Zhao L; Du Y; Wei G; Yao WG; Lee WH
    Neurol Res; 2009 Jun; 31(5):483-9. PubMed ID: 19500451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPE and GPE analogues as promising neuroprotective agents.
    Cacciatore I; Cornacchia C; Baldassarre L; Fornasari E; Mollica A; Stefanucci A; Pinnen F
    Mini Rev Med Chem; 2012 Jan; 12(1):13-23. PubMed ID: 22070686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.
    Guan J
    CNS Neurosci Ther; 2011 Aug; 17(4):250-5. PubMed ID: 20236140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
    Guan J; Krishnamurthi R; Waldvogel HJ; Faull RL; Clark R; Gluckman P
    Brain Res; 2000 Mar; 859(2):286-92. PubMed ID: 10719076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury.
    Lu XC; Chen RW; Yao C; Wei H; Yang X; Liao Z; Dave JR; Tortella FC
    J Neurotrauma; 2009 Jan; 26(1):141-54. PubMed ID: 19119917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.